STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $250,783 | -16.0% | 23,592 | -34.2% | 0.03% | -15.0% |
| Q1 2023 | $298,514 | -20.1% | 35,836 | -11.4% | 0.04% | -33.3% |
| Q4 2022 | $373,464 | +86.7% | 40,462 | +159.2% | 0.06% | +100.0% |
| Q3 2022 | $200,000 | -36.1% | 15,611 | -34.0% | 0.03% | +7.1% |
| Q2 2022 | $313,000 | -63.6% | 23,670 | -7.4% | 0.03% | -50.9% |
| Q2 2021 | $860,000 | +232.0% | 25,554 | +283.9% | 0.06% | +200.0% |
| Q1 2021 | $259,000 | – | 6,657 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |